XBIOTECH INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
XBIOTECH INC. (XBIT) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $0 for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-10.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2023-05-10
- XBIOTECH INC. effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2023-03-31 was $0.00.
- XBIOTECH INC. effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2022-03-31 was $0.00.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 3 month |
|---|---|
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |